Efficacy of Risankizumab on Symptoms in Patients With Scalp Psoriasis in a Post-Hoc Analysis of the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16. J of Skin 2025, 9 (6), s636. https://doi.org/10.25251/57ey8s02.